No evidence for predictors of response to atomoxetine treatment of attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder

J Child Adolesc Psychopharmacol. 2015 May;25(4):372-5. doi: 10.1089/cap.2014.0142. Epub 2015 Apr 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenergic Uptake Inhibitors / therapeutic use*
  • Atomoxetine Hydrochloride / therapeutic use*
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Autism Spectrum Disorder / complications*
  • Child
  • Female
  • Humans
  • Male

Substances

  • Adrenergic Uptake Inhibitors
  • Atomoxetine Hydrochloride